바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기


진료과

  • 연세암병원-방사선종양학과, 두경부암센터, 식도암센터, 폐암센터

전문진료분야

  • <방사선종양학과> 폐암,식도암,두경부암,비뇨기암

진료시간표

인터넷진료예약 ...
의사시간표
진료시간
오전 암병원 암병원
오후 암병원 암병원

교육 및 임상 경력

  • 1985-  1989.    연세의료원    세브란스병원    인턴,  치료방사선과    전공의   
  • 1989-  1992.    공중보건  전문의
  • 1992-  1994.    연세의대    치료방사선과학교실    강사       
  • 1994-  현재.      연세의대    방사선종양학교실  전임강사,  조교수,  부교수.  교수   
  • 1997-  1999.      Massachusetts  General  Hospital,  Dept.  of    Radiation  Oncology,  Hvard    Medical  School,  USA  연수       
  • 2001-  2007.    세브란스호스피스  실장       
  • 2002-  2007.    대한두경부종양학회    이사       
  • 2002-  2011.    한국호스피스완화의료학회    법제이사       
  • 2004-  2011.    대한방사선종양학회  보험이사       
  • 2009-  2013.    연세의대  방사선종양학교실  주임교수   
  • 2009-  2011.    강남세브란스병원    방사선종양학과장   
  • 2011-  2013.    세브란스병원    암센터    방사선종양학과장   
  • 2013-  현재.      연세의대  학생진료개발위원회  위원장
  • 2011-  2015.    한국호스피스완화의료학회    이사장
  • 2016-  현재.      한국호스피스완화의료학회  이사

학술관련경력

  • 대한방사선종양학회 정회원
  • 대한암학회 정회원
  • 대한두경부종양학회 정회원
  • 한국호스피스.완화의료학회 정회원
  • 미국방사선종양학회(ASTRO) 회원
  • 유럽방사선종양학회(ESTRO) 회원
  • 동아일보 선정 암질환분야 베스트중견의사(2001)
  • 동아일보 선정 치료방사선분야 베스트 닥터(2004)
  • 한국일보 선정 친절암명의(2007)
  • 1999 제 90차 미국암연구학회(AACR) <젊은 과학자상 Young Investigator Award>
  • 2016 대한방사선종양학회 <최우수논문상>

주요 관심분야

  • 폐암(lung cancer), 식도암(Esophageal cancer), 두경부암(Head and Neck ancer), 의 방사선치료(Radiation therapy),
  • 온열치료(Hyperthermia)
  • 호스피스.완화의료

학력사항

  • 연세대학교 의학과 학사(1985)
  • 연세대학교 의학과 석사(1989)
  • 원광대학교 의학과 박사(2011)

논문

  • 조재호, 금웅섭, 이창걸, 김경주, 심수정, 박진호, 정경근, 김태곤, 김동석, 최중언, 서창옥 수모세포종의 방사선치료 후 전두엽하방 재발된 환자에서 원인 분석 및 구제 치료 대한방사선종양학회지 2004;22(3):165-176
  • 서창옥, 조재호, 이창걸, 김경주, 박진호, 이세병, 조삼주, 심수정, 윤덕현, 장종희, 김태곤, 김동석 3차원 입체조형치료에 의한 아교모세포종의 방사선 선량증가연구 대한방사선종양학회지 2004;22(4):inpress
  • Gwi Eon Kim, Woong Sub Koom, Woo-Ick Yang, Sang-Wook Lee, Ki Chang Keum, Chang Geol Lee, Chang Ok Suh, Jee Sook Hahn, Jae Kyung Roh, Joo Hang Kim Clinical Relevance of Three Subtypes of Primary Sinonasal Lymphoma Characterized by Immunophenotypic Analysis Head & Neck 2004:584-593
  • Yong Bae Kim, Gwii Eon Kim, Hong Ryull Pyo, Nam Hoon Cho, Ki Chang Keum, Chang Geol Lee, Jinsil, Chang Ok Suh, and Tchan Kyu Park Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix Int. J. Radiation Oncology Biol. Phys 2004;60(3):822-829
  • 이원희, 이미라, 이창걸, 김영진 팀 접근을 통한 말기 암환자 통증중재 개발 임상간호연구 2004;10(1):172-183
  • 이창걸 정밀방사선치료 대한의사협회지 2004:663-671
  • Young Ho Yun, Chang Geol Lee, Si-young Kim, Sang-wook Lee, Dae Seog Heo, Jun Suk Kim, Keum Seok Lee, Young Seon Hong, Jung Suk Lee and Chang Hoon You The Attitudes of Cancer Patients and Their Families Toward the Disclosure of Terminal Illness Journal of Clinical Oncology 2004;22(2):307-314
  • Neoadjuvant Chemotherapy and Radiation for Inoperable cacinoma of the Maxillary Antrum: A matched-control study.
    COMPUTER GRAPHICS WORLD 23/3 :301-308,2000
  • 폐암방사선치료의 최신지견
    결핵 및 호흡기질환(Tuberculosis And Respiratory Diseases) 49/0 :665-675,2000
  • Anti-Vascular Endothelial Growth Factor Treatment Augments Tumor Radiation Response under Normoxic or Hypoxic Conditions.
    JOURNAL OF NEUROSCIENCE 60/0 :5565-5570,2000
  • Anti-vascular endothelial growth factor treatment augments tumor radiation response
    CANCER RESEARCH 60/19 :5565-5570,2000
  • Hyperfractionated Re-irradiation using a 3-Dimensional Conformal Technique for Locally recurrent carcinoma of the Nasopharynx; Preliminary Results.
    YONSEI MEDICAL JOURNAL 42/1 :55-64,2001
  • A feasibility study using three-dimensional conformal boost technique in locally advanced carcinoma of the nasopharynx
    ACTA ONCOLOGICA 40/5 :582-587,2001
  • Primary squamous cell carcinoma of the parotid gland.
    Am J of Otolaryngol 22/6 :400-406,2001
  • 식도암에서 근치적 절제술 후 방사선치료의 역할
    대한방사선종양학회지(journalofthekoreansocietyfortherapeuticradiologyandoncology) 20/4 :316-322,2002
  • Study of IMFAST segmentation algorithm with CORVUS TPS for intensity modulated radiation therapy.
    의학물리 13/4 :181-186,2002
  • 국한성병기 소세포폐암 환자에서 조기 혹은 지연 교대 방사선-황암제치료의 전향적 연구
    대한방사선종양학회지(journalofthekoreansocietyfortherapeuticradiologyandoncology) 20/2 :116-122,2002
  • 호흡주기에 따른 방사선입체조형치료법의 개발.
    대한방사선종양학회지(journalofthekoreansocietyfortherapeuticradiologyandoncology) 20/1 :41-52,2002
  • 암환자와 가족입장에서 본 호스피스 완화의료 제도화
    대한가정학회지 23/8 :1042-1051,2002
  • 비인두암의 세기변조방사선치료의 초기 결과
    대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 0/0 :0-0,2003
  • 입체조준장치를 이용한 중추신경계의 방사선 입체조형치료 계획
    의학물리 14/2 :90-98,2003
  • 세기조절 방사선치료계획의 최적화 및 치료수행의 효율성 연구
    대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 0/0 :0-0,2003
  • 식도암의 방사선치료
    대한기관식도과학회지 9/1 :54-59,2003
  • 방사선치료 시 환자자세 검증을 위한 분석용 도구 개발
    대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 21/1 :100-106,2003
  • 3차원 입체조형치료에 의한 아교모세포종의 방사선 선량증가 연구
    대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 22/4 :237-246,2004
  • 수모세포종의 방사선치료 후 전두엽하방재발된 환자에서 원인 분석 및 구제 치료
    대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 22/3 :165-176,2004
  • 정밀 방사선치료
    대한의사협회지(Journal Of The Korean Medical Association) / :663-671,2004
  • 팀 접근을 통한 말기 암환자 통증중재 개발
    임상간호연구(Clinical Nursing Research) 10/1 :172-183,2004
  • 편도 편평세포암종의 경부림프절 전이
    대한두경부종양학회지 20/2 :156-160,2004
  • Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 60/ :822-829,2004
  • Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 26/7 :584-593,2004
  • Development of a clinical protocol for home hospice care for Koreans
    YONSEI MEDICAL JOURNAL 46/1 :7-20,2005
  • 말기암이 환자가족에게 미치는 사회경제적 영향 및 관련 요인
    가정의학회지 26/1 :31-39,2005
  • Validation study of the Korean version of the Brief Fatigue Inventory
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT 29/2 :165-172,2005
  • Factors influencing preferences for place of terminal care and of death among cancer patients and their families in Korea
    SUPPORTIVE CARE IN CANCER 13/ :565-572,2005
  • 처방선량 및 치료기법별 치료성적 분석 결과에 기반한 자궁경부암 환자의 최적 방사선치료 스케쥴
    대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 23/3 :143-156,2005
  • 비인강암의 치료 성적과 예후인자 및 치료 실패의 분석
    대한이비인후과학회지-두경부외과학 48/10 :1254-1260,2005
  • 악하선 암의 치료성적과 예후인자
    대한두경부종양학회지 21/2 :201-207,2005
  • The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 65/2 :474-480,2006
  • Validation study of the Korean version of the M. D. Anderson symptom inventory
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT 31/4 :345-352,2006
  • Patient-reported assessment of quality care at end of life: Development and validation of Quality Care Questionnaire-End of Life (QCQ-EOL)
    EUROPEAN JOURNAL OF CANCER 42/ :2310-2317,2006
  • Understanding disparities in aggressive care preferences between patients with terminal illness and their family members
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT 31/6 :513-521,2006
  • A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer
    LUNG CANCER 54/ :365-370,2006
  • Predictive value of p53 and PCNA expression for occult neck metastases in patients with clinically node-negative oral tongue cancer
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY 135/6 :858-864,2006
  • 방사선치료로 인한 통증 및 암성통증에 대한 듀로제식의 효과: 다기관연구
    대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 24/4 :263-271,2006
  • Assessment of clinical relevant fatigue level in cancer
    SUPPORTIVE CARE IN CANCER 15/ :891-896,2007
  • Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors
    GYNECOLOGIC ONCOLOGY 104/1 :58-63,2007
  • Validation study of the Korean version of the McGill Quality of Life Questionnaire
    PALLIATIVE MEDICINE 21/ :441-447,2007
  • Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer
    CANCER 109/9 :1845-1850,2007
  • Chemotherapy use and associated factors among cancer patients near the end of life
    ONCOLOGY 72/ :164-171,2007
  • A single institutional experience of surgically resected thymic epithelial tumors over 10 years - Clinical outcomes and clinicopathologic features
    Oncology Reports 19/ :1525-1531,2008
  • The effect of respiratory motion on forward intensity modulated radiotherapy for breast cancer
    Technology In Cancer Research & Treatment 7/ :207-215,2008
  • Hypofractionated high-dose intensity-modulated radiotherapy (60 Gy at 2.5 Gy per fraction) for recurrent renal cell carcinoma: A case report
    Journal Of Korean Medical Science 23/ :740-743,2008
  • A Novel Method of 3-Dimensional Radiotherapy for Head-and-Neck Cancer Treatment
    Journal Of Nuclear Science And Technology / :302-305,2008
  • A Study on Optimization of Photoneutron Shielding in a Medical Accelerator Room by Using Monte Carlo Simulation
    Journal Of Nuclear Science And Technology S5/ :50-53,2008
  • EARLY CLINICAL EXPERIENCE AND OUTCOME OF HELICAL TOMOTHERAPY FOR MULTIPLE METASTATIC LESIONS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 73/ :1517-1524,2009
  • A Comparison of Treatment Plans using Linac-Based Intensity-Modulated Radiation Therapy and Helical Tomotherapy for Maxillary Sinus Carcinoma
    Technology In Cancer Research & Treatment 8/4 :257-263,2009
  • 비소세포성 폐암으로 수술 후 방사선치료가 시행된 N2병기 환자들에서 다발 부위 종격동 림프절 전이 여부에 따른 N2병기 구분의 임상적 의미
    Journal Of The Korean Society For Therapeutic Radiology And Oncology(대한방사선종양학회지) 27/3 :126-132,2009
  • Superficial Dosimetry for Helical Tomotherapy
    Journal Of The Korean Society For Therapeutic Radiology And Oncology(대한방사선종양학회지) 27/2 :103-110,2009
  • RISK FACTORS AND DOSE-EFFECT RELATIONSHIP FOR MANDIBULAR OSTEORADIONECROSIS IN ORAL AND OROPHARYNGEAL CANCER PATIENTS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 75/4 :1084-1091,2009
  • 신경회로망을 이용한 4차원 방사선치료에서의 조사 표적 움직임 예측
    의학물리 20/3 :132-138,2009
  • Positional Reproducibility and Effects of a Rectal Balloon in Prostate Cancer Radiotherapy
    Journal Of Korean Medical Science 24/5 :894-903,2009
  • Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 32/2 :235-243,2010
  • Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy
    RADIATION ONCOLOGY 5/1 :43-49,2010
  • A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results
    LUNG CANCER 71/1 :55-59,2011
  • Attitudes of cancer patients, family caregivers, oncologists and members of the general public toward critical interventions at the end of life of terminally ill patients
    CANADIAN MEDICAL ASSOCIATION JOURNAL 183/10 :673-679,2011
  • Comparison of elective inguinal node irradiation techniques in anal cancer
    대한방사선종양학회지 29/4 :236-242,2011
  • Is There a Clinical Benefit to Adaptive Planning During Tomotherapy in Patients with Head and Neck Cancer at Risk for Xerostomia?
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 35/3 :261-266,2012
  • Nutritional status of patients treated with radiotherapy as determined by subjective global assessment
    Radiation oncology journal 30/3 :132-139,2012
  • Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: Implications for postoperative radiotherapy
    RADIOTHERAPY AND ONCOLOGY 104/3 :367-373,2012
  • Phase II Study of Cisplatin with Irinotecan as Induction Chemotherapy Followed by Chemoradiotherapy for Unresectable Stage III Non-small Cell Lung Cancer
    ANTICANCER RESEARCH 32/8 :3515-3521,2012
  • IMRT with Simultaneous Integrated Boost and Concurrent Chemotherapy for Nasopharyngeal Cancer: Plan Evaluation and Treatment Outcome
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY 42/12 :1152-1160,2012
  • Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
    Radiation oncology journal 30/4 :182-188,2012
  • The attitudes of Korean cancer patients, family caregivers, oncologists, and members of the general public toward advance directives
    SUPPORTIVE CARE IN CANCER 21/5 :1437-1444,2013
  • Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience
    Radiation oncology journal 31/1 :25-33,2013
  • Stereotactic Body Radiotherapy with Helical Tomotherapy for Pain Palliation in Spine Metastasis
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT 12/4 :363-370,2013
  • Long-term Survival Outcomes Following Internal Mammary Node Irradiation in Stage II-III Breast Cancer: Results of a Large Retrospective Study With 12-Year Follow-up
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 86/5 :867-872,2013
  • Early volumetric change and treatment outcome of metastatic brain tumors after external beam radiotherapy: differential radiotherapy for brain metastasis.
    CLINICAL & TRANSLATIONAL ONCOLOGY 15/11 :889-896,2013
  • A Comparative Planning Study of Step-and-shoot IMRT versus Helical Tomotherapy in a Model Patient
    JOURNAL OF THE KOREAN PHYSICAL SOCIETY 63/7 :1481-1485,2013
  • Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study
    Radiation oncology journal 31/4 :177-184,2013
  • A prospective phase II trial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer
    CANCER CHEMOTHERAPY AND PHARMACOLOGY 73/4 :665-671,2014
  • Preoperative Chemoradiotherapy Effects on Anastomotic Leakage After Rectal Cancer Resection: A propensity score matching analysis
    ANNALS OF SURGERY 259/3 :516-521,2014
  • High-dose Versus Standard-dose Radiotherapy with Concurrent Chemotherapy in Stages II-III Esophageal Cancer
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY 44/6 :534-540,2014
  • Treatment outcome of localized prostate cancer by 70 Gy hypofractionated intensity-modulated radiotherapy with a customized rectal balloon
    Radiation Oncology Journal 32/3 :187-197,2014
  • Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiation
    DIGESTION 90/4 :254-260,2014
  • Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer
    DIGESTIVE AND LIVER DISEASE 46/9 :846-853,2014
  • Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma
    ONCOTARGET 6/4 :2562-2572,2015
  • Successful salvage treatment of myxoid liposarcoma with multiple peritoneal seeding using helical tomotherapy-based intraperitoneal radiotherapy: a case report.
    BMC Research Notes 8/179 :1-9,2015
  • Multi-institutional analysis of T3 subtypes and adjuvant radiotherapy effects in resected T3N0 non-small cell lung cancer patients
    Radiation Oncology Journal 33/2 :75-82,2015
  • Toxicity of Tomotherapy-Based Simultaneous Integrated Boost in Whole-Pelvis Radiation for Prostate Cancer
    YONSEI MEDICAL JOURNAL 56/2 :510-518,2015
  • Electro-hyperthermia inhibits glioma tumorigenicity through the induction of E2F1-mediated apoptosis
    INTERNATIONAL JOURNAL OF HYPERTHERMIA 31/7 :784-792,2015
  • Role of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy
    CANCER RESEARCH AND TREATMENT 74/4 :871-878,2015
  • Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma
    ONCOTARGET 6/42 :44971-44984,2015
  • Patterns of care for patients with nasopharyngeal carcinoma (KROG 11-06) in South Korea
    Radiation Oncology Journal 33/3 :188-197,2015
  • Early treatment volume reduction rate as a prognostic factor in patients treated with chemoradiotherapy for limited stage small cell lung cancer
    Radiation Oncology Journal 33/2 :117-125,2015
  • Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non?Small-Cell Lung Cancer: KCSG-LU05-04
    JOURNAL OF CLINICAL ONCOLOGY 33/24 :2,660-2,669,2015
  • Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer
    CANCER RESEARCH AND TREATMENT 48/1 :45-53,2016
  • Time, Dose, and Volume Responses in a Mouse Pulmonary Injury Model Following Ablative Irradiation
    LUNG 194/1 :81-90,2016
  • Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT 15/1 :122-129,2016
  • Mechanical quality assurance using light field for linear accelerators with camera calibration
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS 32/ :398-402,2016
  • Mast Cells Contribute to Radiation-Induced Vascular Hyperpermeability
    RADIATION RESEARCH 185/ :182-189,2016
  • Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy
    CANCER RESEARCH AND TREATMENT 48/2 :473-482,2016
  • PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma
    ONCOTARGET 7/21 :30691-30701,2016
  • The Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma
    CANCER RESEARCH AND TREATMENT 48/3 :928-941,2016
  • Prognostic value of FDG-PET volumetric parameters in patients with p16-positive oropharyngeal squamous cell carcinoma who received curative resection followed by postoperative radiotherapy or chemoradiotherapy
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 38/10 :1,515-1,524,2016
  • Treatment outcomes of intensity-modulated radiotherapy versus 3D conformal radiotherapy for patients with maxillary sinus cancer in the postoperative setting
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 38/ Suppl :E207-E213,2016
  • IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06)
    STRAHLENTHERAPIE UND ONKOLOGIE 192/ :377-385,2016
  • The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis
    CANCER RESEARCH AND TREATMENT 48/3 :917-927,2016
  • Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 38/Suppl :E1,653-E1,659,2016
  • Electro-hyperthermia up-regulates tumour suppressor Septin 4 to induce apoptotic cell death in hepatocellular carcinoma
    INTERNATIONAL JOURNAL OF HYPERTHERMIA 32/6 :648-656,2016
  • Early hypopharyngeal cancer treated with different therapeutic approaches: a single-institution cohort analysis
    Radiation Oncology Journal 34/4 :280-289,2016
  • Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective
    CANCER RESEARCH AND TREATMENT 49/1 :168-177,2017
  • Physician’s Attitude toward Treating Breakthrough Cancer Pain in Korea
    한국호스피스완화의료학회지 20/1 :18-25,2017
  • Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study
    Radiation Oncology Journal 35/2 :153-162,2017
  • Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy
    CANCER RESEARCH AND TREATMENT 49/3 :669-677,2017
  • Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study
    BMC CANCER 17/1 :598-,2017
  • Palliative radiation therapy in the last 30 days of life: A systematic review
    RADIOTHERAPY AND ONCOLOGY 125/2 :193-199,2017
  • Clinical outcomes of multileaf collimator-based CyberKnife for spine stereotactic body radiation therapy
    BRITISH JOURNAL OF RADIOLOGY 90/1079 :20170523-,2017
  • Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy
    Radiation Oncology Journal 35/2 :163-171,2017
  • Comparison of the Clinical Outcomes of Patients with Squamous Cell Carcinoma of the Tonsil Receiving Postoperative Ipsilateral Versus Bilateral Neck Radiotherapy: A Propensity Score Matching Analysis (KROG 11-07)
    CANCER RESEARCH AND TREATMENT 49/4 :1,097-1,105,2017
  • Tumor Stage-Related Role of Radiotherapy in Patients with an External Auditory Canal and Middle Ear Carcinoma
    CANCER RESEARCH AND TREATMENT 49/1 :178-184,2017
  • Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer
    CANCER RESEARCH AND TREATMENT 50/1 :156-163,2018
  • Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer
    ANTICANCER RESEARCH 38/5 :3,165-3,173,2018
  • The possibility of hormone-mediated PSA derangement in prostate cancer treatment
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH 16/2 :243-250,2018
  • Pancreatic radiation effect in apoptosis-related rectal radiation toxicity
    JOURNAL OF RADIATION RESEARCH 59/5 :529-540,2018
  • Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy
    CANCER RESEARCH AND TREATMENT 50/4 :1,214-1,225,2018
  • Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
    FRONTIERS IN ONCOLOGY 8/ :457-466,2018
  • The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with Radiotherapy
    Journal of clinical medicine 7/ :512-524,2018
  • Elective neck treatment in clinically node-negative paranasal sinus carcinomas: impact on treatment outcome
    Radiation Oncology Journal 36/4 :304-316,2018
  • The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106)
    CANCER RESEARCH AND TREATMENT 51/1 :12-23,2019
  • Patterns of failures after surgical resection in olfactory neuroblastoma
    JOURNAL OF NEURO-ONCOLOGY 141/2 :459-466,2019
  • High-dose versus standard-dose radiation therapy for cervical esophageal cancer: Retrospective single-institution study
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 41/1 :146-153,2019
  • Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancer.
    RADIATION ONCOLOGY 14/1 :27-35,2019
  • Management of Clinical T1N0M0 Esophageal Cancer
    GUT AND LIVER 13/3 :315-324,2019
  • Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer.
    FRONTIERS IN ONCOLOGY 9/5 :-,2019
  • Patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers: Implications for postoperative radiotherapy target volumes
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 41/11 :3,916-3,923,2019
  • Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement
    DIGESTIVE AND LIVER DISEASE 51/11 :1,610-1,616,2019
  • The role of salvage radiotherapy in recurrent thymoma
    Radiation Oncology Journal 37/3 :193-200,2019

이창걸

진료철학
2002년부터 첨단방사선치료인 세기조절방사선치료(IMRT)를 이용하여 두경부암, 전립선암, 뇌암등에서 치료의 효과를 높이고 합병증을 줄이는 치료를 시행하며 과거에는 포기했던 방사선 재치료에 대해 많은 경험을 갖고 있습니다. 방사선치료의 꽃인 토모테라피(Tomotherapy)를 이용해 과거 치료할 수 없었던 다발성 전이암에 대한 치료를 시행하며 뇌암, 폐암, 간암, 췌장암 , 전립선암진료 및 치료분야에서 합병증을 획기적으로 줄이고 치료효과를 월등하게 높이고 있습니다. 토모테라피를 활용한 치료의 성과를 유럽방사선종양학회에 보고했으며 제 90차 미국암연구학회(AACR)에서 '젊은과학자상' 수상 및 2007년 한국일보선정 친절한 암명의에 등재 등 높은 평가를 받고 있습니다.

콘텐츠 처음으로 이동

네크워크 링크안내/사이트 정보